Early warrants call expected to bring in $10.4M for InVivo

05/7/2013 | MassDevice.com (Boston)

InVivo Therapeutics is poised to obtain $10.4 million from a call for early exercise of warrants it released to investors in 2010. The call could "eliminate a major impediment towards the up-listing of the company's stock to a national securities exchange," the spinal device company said in a release.

View Full Article in:

MassDevice.com (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD